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Abstract. In this paper, we show that [3COP is present 
on endosomes and is required for the formation of vesi- 
cles which mediate transport from early to late endo- 
somes. Both the association of 13COP to endosomal 
membranes as well as transport vesicle formation de- 
pend on the lumenal pH. We find that ~COP, but not 
",/COP, is also associated to endosomes, and that this as- 
sociation is also lumenal pH dependent. Our data, thus, 
indicate that a subset of COPs is part of the mechanism 
regulating endosomal membrane transport, and that 
membrane association of these COPs is controlled by 
the acidic properties of early endosomes, presumably 
via a trans-membrane pH sensor. 
T 
HE  cytoplasmic surface  of some  subcellular  com- 
partments  and vesicles is  known to be  coated by 
specific sets of peripheral membrane proteins (Kreis 
and Pepperkok, 1994), including clathrin and adaptor pro- 
teins (Pearse and Robinson, 1990), COP coatomers (Roth- 
man and Orci, 1992) and COPII proteins (Barlowe et al., 
1994).  Although the proteins which constitute each coat 
are clearly distinct, sequence homologies have been found 
between  some  clathrin-associated  adaptor  proteins  and 
COP coatomers (Duden et al., 1991; Kuge et al., 1993). 
Clathrin is part of the coat of at least two distinct popu- 
lations  of  vesicles,  which  mediate  transport  from  the 
plasma membrane and from the TGN to endosomes (Rob- 
inson, 1992). In addition to clathrin, the coat of each vesi- 
cle population is formed by a complex of specific, but ho- 
mologous, adaptor proteins, AP1 and AP2 on TGN- and 
plasma  membrane-derived  vesicles,  respectively.  Both 
COP and COPII are involved at early stages of the biosyn- 
thetic pathway. COPs  are  required for the formation of 
Golgi-derived vesicles (Orci et al., 1986; Ostermann et al., 
1993) and for membrane transport from the intermediate 
compartment  to  the  Golgi  complex  (Pepperkok  et  al., 
1993). In yeast, however, formation of ER-derived vesicles 
requires COPII (Barlowe et al., 1994), as well as the small 
GTP-binding protein Sarlp (D'Enfert et al., 1991). In ad- 
dition, Sarlp also promotes vesicle budding from the ER, 
but not the Golgi, in mammalian cells (Kuge et al., 1994). 
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Thus, the COP and COPII coats may be associated to ei- 
ther two parallel or two sequential transport steps from 
the ER to the Golgi. These coats may also support trans- 
port in opposite directions, as suggested by recent studies 
showing that retrieval of di-lysine tagged proteins to the 
ER depends on COPs (Letourneur et al., 1994). 
Except for the AP2/clathrin coat at the plasma mem- 
brane, relatively little is known about the possible involve- 
ment of coat proteins in the endocytic pathway. At the 
electron  microscope  level,  early  endosomal membranes 
were shown to contain clathrin-coated pits with a diameter 
smaller than on the  plasma  membrane; these  pits  were 
proposed to mediate membrane recycling back to the cell 
surface (Killisch et al., 1992). Nonclathrin-coated domains 
have also been observed on early endosomal membranes 
(Par*on, R., unpublished result), but the identity and role 
of these  putative  coat  proteins  are  unknown.  Whereas 
GTP-binding proteins of the ARF/sar family regulate coat 
assembly at  different steps  of the  biosynthetic pathway 
(D'Enfert  et  al.,  1991; Orci  et  al.,  1993a;  Stammes  and 
Rothman, 1993), their role in the endocytic pathway is not 
clear. In vitro studies may suggest that an ARF protein is 
involved in endosome fusion (Lenhard et al., 1992), while 
overexpression of a mutant ARF6 defective in nucleotide 
binding caused accumulation of nonclathrin-coated struc- 
tures  on  peripheral  tubules,  and  reduced  transferrin- 
receptor recycling (D'Souza-Schorey et al., 1994; Peters et 
al., 1994).  Brefeldin A, a  drug which inhibits the Golgi- 
associated ARF1 exchange factor (Donaldson et al., 1992; 
Helms and Rothman, 1992), was shown to affect the mor- 
phology of endosomes (Lippincott-Schwartz et al., 1991; 
Tooze and Hollinshead, 1991; Wood and Brown, 1992), 
but the  molecular events causing these changes  are  not 
clear. Finally, expression of ~COP,  a  component of the 
COP coat (Hara-Kuge et al., 1994), could correct pleiotro- 
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in a mutant CHO cell line (Guo et al., 1994). 
In previous studies, we have observed that tracers en- 
docytosed in BHK cells first appear in early endosomes, 
then in intermediate vesicles with the typical morphology 
of multivesicular endosomes, and finally in late endosomes 
(Gruenberg et al., 1989). Our in vitro studies indicate that 
these vesicles, which we term endosomal carrier vesicles 
(ECVs) 1, are obligatory transport intermediates between 
early and late endosomes, since ECVs are only fusogenic 
with late  endosomes, but not with early endosomes nor 
with  each other  (Gruenberg et  al.,  1989;  Bomsel et  al., 
1990; Aniento et al.,  1993a). We also observed that neu- 
tralization of the vacuolar pH with bafilomycin A1, a spe- 
cific inhibitor  of the  vacuolar ATPase  (Bowman  et  al., 
1988), blocks ECV formation in vivo (Clague et al., 1994). 
The former treatment had no effect on internalization into 
and recycling from early endosomes in vivo, or on endo- 
some fusion properties in vitro. In the present paper, we 
have investigated the mechanisms of ECV formation from 
early endosomes using an in vitro assay.  Our data show 
that  ~COP  is  associated  to  early endosomes  and  is  in- 
volved in ECV formation. Our observations also suggest 
that some, but not all, COPs are involved in this process, 
and that coat formation is controlled by the acidic proper- 
ties of early endosomes, presumably via a trans-membrane 
pH sensor. 
Materials and Methods 
Cells, Viruses, and Immunological Reagents 
Monolayers of BHK-21  cells were  grown and maintained as described 
(Gruenberg et al., 1989).  For each experiment, a minimum of 6  ×  10 cm 
Petri dishes were seeded 16 h before use. Vesicular stomatitis virus (VSV) 
was produced as described (Gruenberg et al., 1989).  All manipulations of 
the cells were at 4°C, except when indicated. The P5D4 monoclonal anti- 
body against the cytoplasmic domain of the spike glycoprotein G  of VSV 
(Kreis, 1986) was a gift of T. Kreis (University of Geneva, Geneva, Swit- 
zerland), as well as the M3A5, maD, A1, El,  and D1 antibodies against 
13COP  peptides  (Allan  and  Kreis,  1986;  Pepperkok  et  al.,  1993).  The 
CM1A10 anti-coatomer antibody (Orci et al., 1993b) and the anti-~COP 
antibody (Hara-Kuge et al., 1994) were gifts from J. Rothman (Sloan-Ket- 
tering Institute, New York, NY). The antibody against ~COP (Stenbeck et 
al., 1992)  was a gift from F. Wieland (Ruprecht Karls University, Heidel- 
berg, Germany). The antibody against ERGIC53 was a  gift from H.-P. 
Hauri (Biocenter, Basel, Switzerland). The monoclonal antibodies against 
rab5a and rab3a were gifts from R. Jahn (Yale University, New Haven, 
CT), and the monoclonal antibody against the transferrin receptor was a 
gift from I. Trowbridge  (Salk  Institute, San Diego,  CA). The antibody 
against annexinII was a gift from V. Gerke (University of MOnster, MOn- 
ster, Germany). 
Subcellular Fractionation of  Endosomes 
Endosomes were separated from each other and from the plasma mem- 
brane using a step flotation gradient, as described (Chavrier et al., 1991; 
Gorvel et al., 1991; Aniento et al., 1993a; Emans et al., 1993). Briefly, cells 
were homogenized gently to limit damage that may be caused to endo- 
somes, and a postnuclear supernatant (PNS) was prepared. The PNS was 
adjusted to 40.6% sucrose, 3 mM imidazole, pH 7.4, loaded at the bottom 
of an SW60 tube, and then overlaid sequentially with 35 and 25% sucrose 
solutions in 3 mM imidazole, pH 7.4, and then with homogenization buffer 
1. Abbreviations used in this paper: bHRP, biotinylated HRP; ECV, endo- 
somal carrier  vesicle; FI  r, floated fraction; HB,  homogenization buffer; 
HSP, high-speed pellet; PF, pelleted fraction; PNS, postnuclear superna- 
tant; VSV, vesicular stomatitis virus. 
(HB; 250 mM sucrose, 3 mM imidazole, pH 7.4). The gradient was centri- 
fuged for 60 min at 35,000 rpm using an SW60 rotor.  Early endosomes 
were then collected at the 35%/25% interface and both ECVs and late en- 
dosomes at the 25%/HB interface. In immunoisolation experiments, en- 
dosomal fractions were  prepared  using the  same gradient,  except  that 
16% sucrose and 10% sucrose in D20 were used instead of 35 and 25% 
sucrose, respectively (Gorvel et al., 1991). 
Early and late endosomes were immunoisolated using as antigen the 
cytoplasmic domain of the spike glycoprotein G of VSV (Gruenberg et al., 
1989;  Howell  et  al.,  1989;  Aniento  et  al.,  1993a;  Emans et  al.,  1993). 
Briefly, the G  protein was implanted into the plasma membrane by low 
pH-mediated fusion of the viral envelope with the plasma membrane and 
then internalized for 5 min at 37°C to label early endosomes or for 45 min 
at 37°C to label late endosomes. The cells were then homogenized and 
fractionated in the gradient, as described above. Early and late endosomal 
fractions were  collected  and used as input in  immunoisolation experi- 
ments. For immunoisolation, we used magnetic beads (M-450 Dynabeads) 
with coupled antibodies against mouse IgG as solid support and the P5D4 
antibody against the cytoplasmic domain of the G protein as specific anti- 
body (Kreis, 1986). Alternatively, endosomes were immunoisolated using 
the maD or the M3A5 antibody against 13COP as specific antibody. 
In Vitro Formation of  ECVs  from Early Endosomes 
To  provide  a  marker of the  early endosomal content  (Aniento  et  al., 
1993a; Emans et al., 1993; Gruenberg et al., 1989), cells were incubated for 
5 min in the presence of 5 mg/ml HRP. The cells were then homogenized 
and early endosomes were separated from ECVs and late endosomes af- 
ter flotation on the gradient (see above). The early endosomal fraction 
was then diluted to  ~0.2 mg protein/ml with HB, adjusted to  12.5  mM 
Hepes, pH 7.0,  1 mM DTF,  1.5 mM MgOAc, 60 mM KCI, and supple- 
mented with an ATP regenerating system (Gruenberg and Howell, 1986) 
and 4 mg/ml rat liver cytosol (Aniento et al., 1993b).  In the assay, the mix- 
ture, containing 300-500 l~g of early endosomal protein in a final volume 
of 1.4-2.3 ml, was incubated for 30 min at 37°C. After the incubation, the 
mixture containing both donor early endosomes and vesicles formed in 
vitro was brought to 25% sucrose, 3 mM imidazole, pH 7.4, loaded at the 
bottom of an SW60 tube and overlaid with HB. After 1 h centrifugation at 
35,000 rpm, donor early endosomes (pelleted  fraction; PF)  and budded 
vesicles (floated fraction; FF) were recovered from the pellet and the 25 % 
sucrose/HB interface, respectively. Both fractions were re-centrifuged for 
30 min at 100,000  g  to sediment membranes, and the HRP activity was 
quantified in the pellets. For SDS gel electrophoresis, membranes were 
washed during a  second centrifugation step in HB containing 150  mM 
NaCI to remove loosely bound cytosolic factors, before solubilization in 
gel sample buffer. 
In some experiments, the cytosol was depleted of coatomer using the 
CM1A10 anti-coatomer antibody, as reported by Orci et al. (1993b). The 
cytosol was incubated with the antibody for 90 min at 4°C and then for an 
additional 60-rain time period with protein A~Sepharose coupled to rab- 
bit anti-mouse IgG. After removal of the immune complex, both 13 and 
eCOP were reduced to -~15-20% of the original amounts. In controls, the 
anti-13COP antibody was replaced by an irrelevant antibody (P5D4).  A 
fraction highly enriched in coatomer was prepared by high speed centrifu- 
gation (200,000 g, 2 h) of rat liver cytosol, as established by F. Wieland 
(Ruprecht Karls University, Heidelberg, Germany). The high-speed su- 
pernatant then retained only ~-20% of both 13 and eCOP. The high-speed 
pellet (HSP) enriched in coatomer was resuspended in HB and used in the 
assay. 
In Vitro Fusion of  ECVs with Late Endosomes 
The fusion properties of vesicles formed in vitro were measured using an 
assay we have established (Gruenberg et al.,  1989;  Bomsel et al., 1990; 
Gorvel et al., 1991; Aniento et al., 1993a).  Formation of vesicles in vitro 
was as above, except that biotinylated HRP (bHRP) was used to label the 
vesicle content, instead of HRP. Then, ECVs formed in vitro were sepa- 
rated from donor membranes by flotation as described above, except that 
the reaction mixture was loaded onto a 35% sucrose cushion in 3 mM imi- 
dazole, pH 7.4, to avoid pelleting of the donor membranes. Thus, donor 
early endosomal membranes (PF) were collected at the interface between 
35 and 25% sucrose, and ECVs formed in vitro (FF) at the interface be- 
tween 25%  sucrose and homogenization buffer. In control experiments, 
early endosomes labeled with bHRP internalized for 5 min at 37°C were 
prepared  as above using the gradient. The total bHRP activity of each 
fraction used in the fusion assay was always identical, so that experiments 
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beled with avidin after incubation at 37°C for 5 min, or 5 min followed by 
a  40-rain chase in marker-free medium, respectively (Gruenberg et al., 
1989; Gorvel et ai., 1991; Aniento et al., 1993a). After homogenization, a 
PNS was prepared and used in the fusion assay, as described (Gruenberg 
et al., 1989).  In the assay, bHRP-labeled vesicles formed in vitro (50 p,1 
containing 5-10 p,g protein) were mixed with 70 p~l PNS containing avidin- 
labeled endosomes, and then supplemented with 30 Ixl rat liver cytosol 
(20 mg protein/ml), an ATP-regenerating or -depleting system,  0.05 mg/ml 
biotinylated insulin, 60 mM KOAc, 1.5 mM MgOAc, 1 mM DTT, and 12.5 
mM Hepes, pH 7.4, and the mixture was incubated for 45 min at 37°C. In 
some experiments, endogenous tubulin was polymerized in the assay us- 
ing 20 IxM taxol (Bomsel et al., 1990; Aniento et al., 1993a). Then the avi- 
din-bHRP complex formed upon membrane fusion was extracted in de- 
tergent, immunoprecipitated with anti-avidin antibodies and the enzymatic 
activity of bHRP was quantified. To calculate fusion efficiency, this value 
was expressed as a percentage of the total amount of avidin-bHRP com- 
plex formed in the presence of detergent and in the absence of biotiny- 
lated insulin. 
Electron Microscopy 
For electron microscopic localization studies, BHK cells were grown on 
polylysine-coated coverslips for 2 d before the experiment. The cells were 
washed and incubated with 10 mg/ml HRP for 10 min at 37°C to label 
early endosomes. They were then washed with cold PBS and transferred 
to ice.  Rip-off of the dorsal surface was performed as described by De 
Curtis and Simons (1989). Briefly, a nitrocellulose filter was laid on top of 
the coverslips in contact with the cells. After applying slight pressure to 
the nitrocellulose using a  bent glass pipette,  the nitrocellulose was re- 
moved. All the following steps, before fixation, were performed on ice. 
The cells were then incubated for 10 min in 12.5 mM Hepes, pH 7.0 buffer, 
containing 75 mM KC1, 1.5 mM MgOAc and 0.1%  BSA, and then incu- 
bated in the same buffer for 30 rain with either the M3A5 anti-13COP anti- 
body or with a control monoclonal antibody at exactly the same concen- 
tration.  After washing the cells over 30 min, they were  then incubated 
with gold-labeled second antibodies (Aurion, Wageningen, The Nether- 
lands). The cells were washed to remove unbound gold, fixed in 2.5% glu- 
taraldehyde in 50 mM cacodylate, and then processed for Epon embed- 
ding  as  previously  described  (Parton  et  al.,  1992).  Sections  were  cut 
parallel to the substratum and viewed without further contrasting. 
When analyzed in plastic sections, fractions containing HRP-labeled 
donor membranes (PF) or vesicles formed in vitro (FF) were prepared as 
described above, and centrifuged for 30 min at 100,000 g. The membrane 
pellets were fixed, reacted with diaminobenzidine, and processed for elec- 
tron microscopy as described (Parton et al., 1989; Bomsel et al., 1990).  In 
some experiments, the assay measuring vesicle formation was carried out 
in the presence of GTP~S and M3A5 anti-13COP antibody. Then, rabbit 
anti-mouse IgG and protein A-gold were added.  Membranes were col- 
lected by centrifugation in a sucrose step flotation gradient at the 35-10% 
interface and then re-centrifuged for 30 min at 100,000 g. The membrane 
pellets were fixed, reacted with diaminobenzidine, and processed for elec- 
tron microscopy. 
Analytical Techniques 
Quantification of protein was according to (Bradford, 1976). Western blot 
analysis was carried out using peroxidase-conjugated sheep anti-mouse or 
goat anti-rabbit IgG as secondary antibodies and detected by chemilumi- 
nescence using the ECL reagent (Amersham Corp., Arlington Heights, 
IL). Western blots exposed in the linear range of detection, as established 
with controls, were  quantitated using a  GS300 transmitance/reflectance 
scanning densitometer (Hoefer Scientific Instruments, San Francisco, CA). 
Results 
flCOP (or a Closely Related Homologue)  Is Present in 
Endosomal Fractions 
We have tested whether 13COP could be detected on en- 
dosomes of BHK cells. As a first step, we have analyzed 
endosomal fractions obtained by flotation in a step gradi- 
ent which we have established. In this gradient, early en- 
dosomes,  containing  annexinlI  and  the  small  GTPase 
rab5, equilibrate at the interface between two cushions of 
35 and 25% sucrose, whereas late endosomes, containing 
the rab7 protein as well as the mannose-6-phosphate re- 
ceptor and lysosomal glycoproteins, are found at a lighter 
position corresponding to the  interface between 25  and 
8.5%  sucrose (Chavrier et al.,  1991;  Gorvel et al.,  1991; 
Aniento et al., 1993a; Emans et al., 1993). A detailed anal- 
ysis of the in vitro fusion properties and protein composi- 
tion of these fractions revealed that ECVs equilibrate at 
the  same  position  as  late  endosomes  (Aniento  et  al., 
1993a). 
A  Western blot analysis revealed the presence of pro- 
teins migrating at the position of 13COP and ¢COP in both 
early and late endosomal fractions (Fig. 1 A, EE and LE, 
respectively). In contrast, these fractions did not contain 
detectable amounts of ~/COP. Previously, the bulk of 13COP 
was shown to localize to early stages of the biosynthetic 
pathway after immunogold labeling of cryosections using 
an antibody raised against a 13COP peptide (Duden et al., 
1991; Pepperkok et al., 1993). We therefore analyzed the 
distribution of the intermediate compartment between ER 
and Golgi in our gradient, using antibodies against ERGIC53 
(Schweizer et al.,  1988).  The bulk of ERGIC53,  I~COP, 
and ¢COP was recovered, as expected, in the same frac- 
tion (heavy membranes, Fig. 1 A, HM), at the interface be- 
tween the load and the 35%  sucrose cushion, well sepa- 
rated from endosomes. Quantification of the gels showed 
that the early endosomal fraction contained only -~10% of 
the amounts of ERGIC53 present in the HM fraction and 
<5% of 7COP, but 55-70% of ¢ and 13COP (Fig. 1 B). It 
is, however, not clear whether these values really reflect 
the intracellular distribution of 13 and ~COP, or whether 
the endosomal forms of these proteins are preferentially 
recognized by the antibodies we used. Moreover, both 
and 13COP were also present in late endosomal fractions, 
but neither ERGIC53  nor ~/COP  (even after long expo- 
sures of the gels). To ensure that the presence of COPs in 
endosomal fractions did not reflect spurious membrane as- 
sociation  of the  protein  after  homogenization,  we  pre- 
pared  mitochondria and  Golgi/endosome fractions from 
rat liver (Aniento et al., 1993b). A  Western blot analysis 
showed that 13COP was indeed present in the latter frac- 
tion, as expected, but absent from the mitochondrial frac- 
tion (not shown). These observations may suggest that 13 
and ¢COP, but not ~/COP, are associated to endosomes. 
Immunoisolation of Early Endosomes 
We then used  immunoisolation to determine whether 13 
and  ~COP  were  indeed  present  on  early  endosomes 
(Gruenberg et al., 1989; Howell et al., 1989; Aniento et al., 
1993a;  Emans et al.,  1993). The spike glycoprotein G  of 
VSV  was  implanted  into  the  plasma  membrane by low 
pH-mediated fusion of the viral envelope with the plasma 
membrane, and then internalized for 5 rain at 37°C to label 
early endosomes. After homogenization, endosomes were 
fractionated on the gradient and then immunoisolated on 
magnetic beads (Dynabeads M-450) with bound antibod- 
ies against the cytoplasmic domain of the G protein (Kreis, 
1986). As shown in Fig. 1 A, both 13 and ¢COP, but neither 
ERGIC53 nor ~/COP,  were specifically associated to im- 
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of COPs and ERGIC53 was studied in BHK cytosol and in 
BHK subcellular fractions by SDS-PAGE followed by West- 
ern blotting, using antibodies against ERGIC53, ¢ or ~/COP, 
and the M3A5 antibody against [3COP. The PNS was loaded 
at the bottom of a sucrose flotation gradient, and, after cen- 
trifugation, fractions were collected: heavy membranes (HM), 
40.6%/35% interface; early endosomes (EE) 35%/25% inter- 
face;  late  endosomes  (LE)  25%  sucrose/homogenization 
buffer interface. In all lanes, 15 p,g protein was loaded. Early 
endosomes were further purified from 60 i~g EE fraction by 
immunoisolation (II-EE). Then, the VSV-G glycoprotein was 
implanted into the plasma membrane and then internalized 
for 5 min at 37°C. After the gradient, early endosomes were 
retrieved using anti-mouse magnetic beads without (control, 
ctrl.) or with the P5D4 antibody against VSV-G cytoplasmic 
domain (specific, sp.) (B) The distribution of ERGIC53, [3, ¢, 
and ~/COP in the gradient fractions (,4) was quantified by den- 
sitometric scanning of the blots.  To facilitate  comparison, the 
amounts of each marker present in the HM fraction was nor- 
malized to 100%.  (C) Immunoisolated early endosomes (II- 
EE in A) were incubated in vitro in the presence of 1 mg/ml 
BHK  cytosol with  (GTPyS)  or  without  (control) 50  oLM 
GTP~/S, washed,  and  analyzed by SDS-PAGE followed by 
Western blotting with antibodies against [3 or ¢COP, as in A. 
(D) HRP was internalized  for 5 min at 37°C and then cells 
were fractionated as in A, but immunoisolation was carried 
out with the following antibodies: No Ab, no antibody; P5D4, 
control with P5D4 antibody; anti-flll3radaptin,  antibody against 
both [31 and [32 adaptins; M3A5 and maD, antibodies against 
different [3COP peptides. The HRP activity associated to the 
beads was quantified and expressed as a percentage of the to- 
tal HRP activity originally present in the fraction. (E) As in D, 
but analysis was by SDS-PAGE and Western blotting with an- 
tibodies  against  the  transferrin  receptor  (Tfn-R)  or against 
rab5. For comparison, the starting early endosomal fraction 
(EE) was also analyzed, rab5 migrates at a position close to 
the light chain of the IgG used in immunoisolation (IgG 1.c.). 
munoisolated early endosomal membranes. We then tested 
whether  [3 and eCOP association to endosomes was, as is 
the case in the biosynthetic pathway, sensitive to GTP~/S. 
As shown in Fig. 1 C, the amounts of [3 and ¢COP present 
on immunoisolated early endosomes were significantly in- 
creased  after  incubation  in  the  presence  of cytosol and 
GTP~/S, indicating that COP recruitment onto endosomal 
or biosynthetic membranes share some mechanistic simi- 
larities. 
As  a  next  step,  we  investigated  whether  early  endo- 
somes could also be  immunoisolated  using two different 
anti-[3COP  antibodies  (M3A5  or  maD).  The  antibodies 
were  bound  to  the  same  solid  support  and  the  complex 
was  added  to  endosomal  fractions  which  had  been  col- 
lected from the gradient,  as above. In these experiments, 
we used horseradish peroxidase  internalized  for 5  min at 
37°C as marker of the early endosomal content,  and the 
transferrin receptor (Hopkins and Trowbridge, 1983; Trow- 
bridge  et  al.,  1993)  as  well  as  the  small  GTPase  rab5 
(Chavrier  et  al.,  1990),  as  markers  of  early  endosomal 
membranes. Fig. 1 (D and E) shows that the three markers 
were  specifically  retrieved  with  either  anti-[3COP  anti- 
body, but not with control antibodies nor with antibodies 
recognizing the  clathrin-associated  [31  adaptin  as  well  as 
the  [32  adaptin,  which  has  some  homology  to  [3COP 
(Duden et al.,  1991). Altogether, these experiments show 
that [3 and ¢COP, but not ~/COP, are present on early en- 
dosomal membranes. 
Electron Microscopy Analysis of flCOP on 
Early Endosomes 
We then investigated whether [3COP could be detected on 
early  endosomal  membranes  by  electron  microscopy. 
Since neither the M3A5 nor the maD antibody recognized 
their antigen on cryosections, we used a pre-embedding la- 
beling  technique.  Cells  were  first  incubated  in  the  pres- 
ence of HRP for 10 rain at 37°C, to label the early endoso- 
mal lumen, and then the dorsal surface of the cells was tipped 
off with  nitrocellulose  (De  Curtis  and  Simons,  1989)  to 
gain access to the cytoplasm. The opened cells were then 
treated  with  the M3A5  antibody against  [3COP followed 
by gold-labeled second antibody, and then the cells were 
processed  for electron  microscopy. Fig. 2  shows that  the 
anti-[3COP antibody, but not the control antibody, specifi- 
cally labeled early endosomes containing internalized HRP. 
In Vitro Budding of Endosomal Carrier Vesicles 
The fact that 13 and eCOP were present in both early and 
late  endosomal  fractions  (Fig.  1 A)  suggested  that  these 
The Journal of  Cell Biology.  Volume 133, 1996  32 Figure  2.  Endosome  localiza- 
tion of 13COP in permeabilized 
cells. Cells were incubated with 
HRP for 10 rain at 37°C to label 
early endosomes, and were then 
permeabilized.  The  permeabi- 
lized  cells were then incubated 
with the M3A5 anti-13COP anti- 
body (A and B) or an irrelevant 
control  antibody  (C)  followed 
by gold-labeled  second antibod- 
ies. HRP-labeled endosomes are 
labeled by the anti-13COP anti- 
body (A and B, arrowheads) but 
not  by  control  antibodies  (C); 
gold  particles  indicated  by ar- 
rowheads,  HRP-labeled  endo- 
some by an  arrow.  The  rough 
endoplasmic reticulum  (rer) and 
mitochondria (m) show lower la- 
beling with the M3A5  antibody 
(A and B). Bars, 100 nm. 
proteins may be involved in membrane transport between 
early and late endosomes. We, therefore, decided to estab- 
lish  an  in  vitro  assay measuring  ECV  formation and  to 
make use of the large panel of antibodies available against 
[3COP  to  test  whether  the  protein  was  involved in  this 
process. 
Cells were incubated for 5 min at 37°C in the presence of 
HRP, to provide a marker of the early endosomal content. 
Early  endosomes  were  then  separated  from  the  lighter 
ECVs and late endosomes, using the flotation gradient. In 
the assay, these early endosomal fractions were incubated 
at 37°C in the presence of ATP and cytosol, to allow for- 
mation of ECVs from early endosomes to occur in vitro. 
The mixture was then loaded on a similar flotation gradi- 
ent, to separate ECVs formed in vitro from the denser do- 
nor membranes (early endosomes).  After centrifugation, 
the HRP activity of the FF (containing vesicles formed in 
vitro) and PF (containing donor membranes) was quanti- 
fied. Thus, the assay measures the percentage of the total 
early endosomal content entrapped within vesicles formed 
in the assay. 
As shown in Fig. 3 A, vesicle formation in vitro occurred 
at  37°C,  but  not  at  4°C,  and  required  both  cytosol  and 
ATP. The process was rapid (Fig. 3 B), like other budding 
events in vitro (Salamero et al., 1990; Tooze and Huttner, 
1990;  Rexach  and  Schekman,  1991):  within  5-10  min 
~10%  of the  original  early endosomal volume was  en- 
trapped within vesicles formed in vitro. We also observed 
that vesicle formation was inhibited by low concentrations 
of  GTP~/S  (Fig.  3  A  and  see  Discussion).  Addition  of 
GTP~S, or any one of the other treatments, had no effect 
on the sedimentation properties of early or late endosomal 
membranes  in  continuous  sucrose  gradients  (data  not 
shown).  Western  blotting of SDS gels with two different 
anti-13COP antibodies showed that vesicles formed in vitro 
contained [3COP, as predicted (Fig. 3 C). The low amounts 
of ERGIC53  originally  present  in  the  early  endosomal 
fraction (Fig. 1) remained associated to donor membranes 
after the  assay (Fig. 3  C). Finally, ECVs formed in vitro 
contained <5% of the amounts of rab5 and transferrin re- 
ceptor remaining in donor membranes after the assay (Fig. 
3 C). These observations indicate that the floated fraction 
was not contaminated with early endosomal vesicles, and 
that both rab5 and the transferrin receptor were excluded 
from ECVs formed in vitro, as in vivo. These experiments 
also show that the floated fraction did not  contain recy- 
cling  vesicles  destined  to  carry  the  transferrin  receptor 
back to the plasma membrane. 
Aniento et al. BCOP and pH in Endosomal Transport  33 A  lO 
2 
:D 
_c  6 
C 
O 
4 
o 
O 
S  2 
S  10. 
~,  8. 
.c_  6. 
i4 
>:.  2 
0  -  .  .  .  .  ,  .  .  •  .  .  ,  •  , 
0  2O  4O  6O 
Time (rain) 
Figure 3.  In vitro formation 
of  ECVs.  (A)  Early  endo- 
somes containing HRP inter- 
nalized  for  5  min  at  37°C 
were  prepared  by  flotation 
on a  sucrose  gradient, as in 
Fig. 1. In the assay, early en- 
dosomal  fractions  were  di- 
luted with cytosol  and incu- 
bated  for  30  min  at  37°C. 
Vesicles formed in vitro were 
then  separated  from  donor 
early endosomes by flotation 
in a single step gradient.  Af- 
ter  centrifugation,  early en- 
dosomes were  recovered in 
the  pellet,  whereas  vesicles 
formed  in  vitro  were  col- 
lected at the 25 % sucrose/ho- 
mogenization  buffer  inter- 
face, where ECVs formed in 
vivo equilibrate (Aniento et al., 1993a). Then, HRP activity was 
quantified in the fractions, and the efficiency of vesicle formation 
is expressed as a percentage of the total HRP activity originally 
present in the donor early endosomal fraction.  Control, assay 
carried out at 37°C in the presence of cytosol and ATP; -ATP, 
ATP was omitted;  -cytosol, cytosol was omitted; 4°C, the assay 
was at 4°C; GTPTS, 10 ~M GTP~/S was present in the assay. (B) 
The assay was carried out as in A for the indicated  time periods. 
(C) The assay was as in A, but the fractions  were analyzed  by 
SDS-PAGE  followed  by  Western  blotting  with  antibodies 
against  the transferrin receptor (TfnR), rab5 (rabS), ERGIC53 
and two different  anti-13COP antibodies  (M3A5 and El). FF, the 
floated fraction containing  ECVs formed in vitro; PF, the pel- 
leted fraction containing  donor early endosomes.  For compari- 
son, endosomal fractions prepared as in Fig. 1 are also shown. 
EE, early endosomal fraction; LE, late endosomal fraction con- 
taining both late endosomes and ECVs (Aniento et al., 1993a). 
Each lane contained 15  Ixg protein, corresponding to  ~-2×  as 
much HRP in LE and FF fractions, when compared to EE and 
PF fractions, respectively. 
A  morphological analysis showed that the HRP-labeled 
structures  present  in  the  floated fraction were predomi- 
nantly multivesicular with the characteristic appearance of 
ECVs, as expected, whereas the donor fraction contained 
a  large  proportion  of  typical  tubular-  and  ring-shaped 
early endosomal elements (Fig. 4, A  and B, see Table I). 
The complete assay mixture was then incubated without 
or with GTP~/S, which increases 13COP association to en- 
dosomes (Fig. 1 C) but blocks vesicle formation (Fig. 3 A), 
and  then  analysed by immunoelectron microscopy using 
anti-13COP antibodies (Fig. 4, C and D). Under both con- 
ditions,  [3COP was detected on HRP-labeled early endo- 
somal membranes, including at the neck of multivesicular 
structures resembling forming ECVs. The epitope may be 
less accessible on the ECVs, since ECV labeling with these 
antibodies was low. Small (<100 nm) ~COP-coated vesi- 
cles  with  the  characteristic  appearance  of  biosynthetic 
COP-coated  vesicles  (see  Kreis  and  Pepperkok,  1994) 
were not seen in these preparations. Nor did we observe 
an  endosomal  coat  with  the  typical  appearance  of  the 
Golgi COP coat, even after tannic  acid treatment of the 
samples to enhance coat visualization (Orci et al.,  1986). 
These experiments confirm the presence of [3COP on en- 
dosomes, but  also suggest that the endosomal COP coat 
does not only differ in composition but also in morphology 
and/or appearance from the biosynthetic COP coat. 
Endosomal Carrier Vesicles Formed In Vitro Are 
Fusogenic with Late Endosomes 
We had previously shown that ECVs formed in vivo un- 
dergo fusion with late endosomes in vitro, in contrast to 
early  endosomes  (Bomsel  et  al.,  1990;  Aniento  et  al., 
1993a). Here, we tested whether ECVs which were formed 
in vitro from early endosomes had acquired the capacity to 
undergo fusion with late endosomes. Fusion was measured 
by  the  formation  of  a  fusion-specific  complex between 
bHRP and avidin (Gruenberg et al., 1989;  Aniento et al., 
1993a).  ECVs were formed in vitro exactly as described 
above (see Fig. 3, FF), except that bHRP was used instead 
of HRP to label the endosomal content. As a control, we 
also measured the fusion properties of the bHRP-labeled 
donor early endosomes before (EE) and after (PF) bud- 
ding in vitro. In the fusion assay, the total bHRP activity of 
each fraction was identical to that of the ECV fraction, so 
that  different  experiments  could  be  directly  compared. 
Then, the bHRP-labeled vesicles were mixed with endo- 
somes  containing  internalized  avidin  (Aniento  et  al., 
1993a), cytosol and ATP, and then incubated for 45 min at 
37°C.  If fusion occurred, a  complex was formed between 
bHRP and avidin. At the end of the experiment, the com- 
plex was immunoprecipitated with  anti-avidin antibodies 
in the presence of detergent and the enzymatic activity of 
bHRP was quantified. 
As shown in Fig. 5, ECVs formed in vitro have acquired 
the capacity to undergo fusion with late endosomes (FF- 
LE), fusion efficiency being similar to the value measured 
with freshly prepared ECVs  (Aniento  et  al.,  1993a).  As 
previously reported for freshly prepared ECVs (Bomsel et 
al.,  1990;  Aniento  et  al.,  1993a),  interactions  between 
ECVs formed in vitro and late endosomes were facilitated 
by the presence of polymerized microtubules (not shown). 
The  donor  membranes recovered after in  vitro budding 
(PF) retained the typical capacity of the original early en- 
dosomes  (EE)  to  undergo  homotypic fusion  with  other 
early endosomal elements (PF-EE  and EE-EE)  (Gruen- 
berg et al.,  1989).  In addition, the direct fusion of donor 
membranes with late endosomes was comparatively low, 
whether  the  donor  was  tested  before  (EE-LE)  or  after 
(PF-LE) the budding assay, in agreement with our previ- 
ous  observations  (Gorvel  et  al.,  1991;  Aniento  et  al., 
1993a). The low fusion signal which was then detected may 
be  due  to  a  low  contamination  of the  early  endosomal 
fraction with ECVs, or to the formation of new ECVs dur- 
ing the fusion assay (-~10%  of the  early endosomal vol- 
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copy  analysis of  donor  mem- 
branes  (PF)  and  vesicles 
formed  in vitro  (FF).  (A  and 
B)  The  assay was  carried  out 
as  in Fig. 3 A, and then ana- 
lyzed  after  Epon  embedding. 
Main  panels  show  low  mag- 
nification overviews  of HRP- 
labeled elements in the pelleted 
(,4) and floated  (B) fractions. 
The  HRP-labeled  profiles 
comprise  tubules, ring-shaped 
structures (arrows) and spheri- 
cal  multivesicular bodies  (ar- 
rowheads).  Early  endosomal 
elements  with  a  ty~pical ring- 
shaped appearance are present 
in the donor pelleted fraction 
(higher magnification in inset 
to A). When compared to the 
donor  pelleted  fraction,  the 
floated  fraction is enriched in 
spherical  multivesicular  struc- 
tures  (higher magnification in 
insets to B, see Table I). Use of 
tannic  acid  in  an  attempt  to 
stain coats associated with the 
large vesicles revealed no sig- 
nificant COP-like coat.  Some 
electron  dense  material  was 
however associated with some 
multivesicular vesicles  (B,  in- 
set,  small  arrowheads).  Bars, 
0.5 ~m (A-D) and 0.2 i~m (in- 
sets). (C and D) The assay was 
carried out as in Fig. 3 A in the presence of the M3A5 anti-13COP antibody with (D) or without (C) 10 I.LM GTP~/S. The mixture con- 
taining donor membranes was then incubated with second antibodies and protein A-gold, and embedded in Epon using a method to re- 
veal any coat material. Specific labeling is associated with HRP-labeled buds and tubules (large arrowheads) but rarely with the HRP- 
labeled multivesicular domains of early endosome (small double arrowheads). However, panels C (top right corner, no GTP~/S) and D 
(with GTP~S) show examples of 13COP labeling at the neck of structures resembling forming ECVs. Bars, 100 nm. 
ume is entrapped within newly formed ECVs in vitro; Fig. 
3 A).  Our data thus indicate that the fusion properties  of 
both ECVs formed in vitro and donor endosomes (recov- 
ered after in vitro budding) are characteristic of the corre- 
sponding compartments  (Gorvel  et  al.,  1991;  Aniento et 
al., 1993a)  and establish that functional ECVs are formed 
from early endosomes in vitro. 
Formation of ECVs Depends on flCOP 
We then tested whether [3COP was involved in ECV for- 
mation from early endosomes. In these experiments, vesi- 
cles were formed in vitro as described above, except that 
the  reaction mixture was preincubated for 60 rain on ice 
with antibodies against [3COP, before raising the tempera- 
ture to 37°C. As shown in Fig. 6 A, formation of ECVs was 
inhibited by a  polyclonal (D1) or by a  monoclonal (maD) 
antibody against the  same  [3COP peptide,  or by an anti- 
coatomer antibody (CM1A10). The process was also com- 
pletely  abolished  by  the  M3A5  monoclonal  antibody 
against [3COP. The specificity of inhibition observed with 
these  antibodies is entirely consistent with our other bio- 
chemical and morphological observations. The  maD  and 
M3A5 could also be used for endosome immunoisolation 
(Fig.  1,  D  and  E)  and  immunolabeling (Figs.  2  and  4), 
whereas the CM1A10 could be used for immunodepletion 
of cytosolic COPs  (see Fig. 6  C), as previously shown by 
Table I. Morphological Analysis of Donor Early Endosomes 
and Vesicles Formed In Vitro 
Tubular  Ring-shaped  Spherical  Others 
%  %  %  % 
Donor EE  25  31  40  4 
Budded vesicles  3  19  75  3 
Cells were incubated  with HRP for 5 min at 37°C to label  early endosomes,  and ho- 
mogenized. Then,  early endosomes  were purified  by flotation  in the step gradient.  In 
the assay,  these  early  endosomes  were  incubated  at 37°C  in the presence  of cytosol  and 
ATP, to allow formation  of ECVs to occur in vitro (as in Fig. 3). Donor  early endo- 
somes were separated from ECVs after centrifugation  in a similar  gradient. Mem- 
branes were then sedimented,  fixed, and processed for electron microscopy, as in 
(Gorvel et al., 1991). The profiles  containing  internalized  HRP were analyzed.  Ac- 
cording to their morphology  in thick sections,  HRP-positive  structures were counted 
as tubular,  ring-shaped,  or spherical  elements  (see Fig. 4). The number  of profiles for 
each category is indicated  as a percentage  of the total number  of labeled  structures  in 
each fraction,  donor early endosomes  present in the pelleted fraction (Donor  EE) or 
vesicles  formed  in vitro  present  in the floated  fraction  (Budded  vesicles). 
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Figure 5.  ECVs formed in vitro are fusogenic  with late endo- 
somes. The assay measuring vesicle formation in vitro was carried 
out essentially as in Fig. 3, except that the reaction mixture (ad- 
justed to 25% sucrose) was loaded onto a 35% sucrose cushion to 
avoid possible  damage to the donor membranes after pelleting. 
Thus,  after centrifugation,  donor early endosomal membranes 
(PF)  were recovered at the 35/25% sucrose  interface,  whereas 
ECVs formed in vitro (FF) were collected  at the interface be- 
tween 25% sucrose and homogenization buffer. In a second step, 
the fusion  activity of FF and PF fractions  with late endosomes 
(LE, see Fig. 1) was quantified  using our in vitro fusion  assay 
(Aniento et al., 1993a). The results are compared with the fusion 
activity of freshly prepared early endosomes (EE, see Fig. 1). The 
fusion assay itself is described in the text and in the Materials  and 
Methods section.  The homotypic fusion  activity of donor early 
endosomes with fresh early endosomes (PF-EE) is in the same 
range as the fusion activity of fresh early endosomes with each 
other (EE-EE). Neither donor early endosomes (PF-LE), nor 
fresh early endosomes (EE-LE) can undergo direct fusion with 
late endosomes,  as expected (Aniento et al., 1993a). However, 
vesicles formed in vitro and present in the FF fraction have ac- 
quired the competence to undergo fusion with  late endosomes 
(FF-LE), like bona fide ECVs (Aniento et al., 1993a). Hatched 
bars, with ATP; open bars, control without ATP. 
bodies, suggest that 13COP is involved in the formation of 
ECVs from early endosomes. 
As a  next step, we tested the effects of COP depletion 
on vesicle formation in the assay. The cytosol was immu- 
nodepleted  using  the  CM1A10  anti-coatomer  antibody 
(Fig. 6  C), which has been previously used to immunode- 
plete coatomer (Orci et al.,  1993b).  After immunodeple- 
tion, other cytosolic properties required for vesicle forma- 
tion were not altered, since depleted cytosol supported the 
formation  of ECVs  from  control  untreated  membranes 
(not shown).  Since COPs are also present on endosomal 
membranes, cells were treated with nigericin before frac- 
tionation to release endosome-associated COPs (Fig. 6 C; 
see below and Fig. 7 A). Membrane depletion was revers- 
ible, since vesicle formation then occurred at control levels 
in  the  presence of untreated  cytosol when nigericin  was 
omitted in the assay (Fig. 6 B, controls). 
Fig. 6 B shows that depletion of both cytosolic and mem- 
brane pools of 13COP significantly inhibited vesicle forma- 
tion in the assay. To ensure that these treatments were re- 
versible,  low  amounts  of  complete  cytosol  containing 
COPs were  added  to the  assay. Then,  vesicle formation 
from early endosomes was fully restored (Fig. 6 B). This 
effect was not due  to the  presence of some factors with 
general stimulating activity, since addition of extra cytosol 
to the controls did not further increase vesicle formation. 
To test the involvement of COP proteins more directly, a 
high speed pellet highly enriched in COPs was prepared 
after centrifugation of the cytosol (not shown),  as estab- 
lished by F. Wieland (personal communication). Centrifu- 
gation  did  not  alter other  cytosolic properties,  since  the 
high speed supernatant still supported both ECV formation 
from undepleted membranes as well as endosome fusion 
in vitro (not shown). As shown in Fig. 6 B, the COP-enriched 
fraction could restore ECV formation after depletion of 
both cytosolic and membrane pools of COPs. Altogether, 
these depletion-recomplementation experiments, together 
with the effects of anti-13COP antibodies in the assay, dem- 
onstrate that COPs, in particular 13COP, are necessary for 
the formation of vesicles mediating transport from early to 
late endosomes. 
Orci et al. (1993b). In contrast, the A1 antibody had no ef- 
fect in the assay, suggesting that this epitope is not accessi- 
ble on endosomal membranes. 
As  a  control,  we  also  tested  in  the  assay  antibodies 
against the small GTPase rab5, which inhibit early endo- 
some fusion in vitro (Gorvel et al., 1991), and against the 
small GTPase rab3a, which is present on synaptic vesicles 
(Fischer von Mollard et al., 1991). We also tested antibod- 
ies against clathrin-associated a  adaptin, and against both 
131 and 132 adaptins (Robinson, 1992). None of these anti- 
bodies had any effect on ECV formation from early endo- 
somes (Fig. 6 A). Finally, as an additional control, we also 
tested the same antibodies in our assay measuring homo- 
typic fusion of early endosomes (Gruenberg et al., 1989). 
Whereas fusion was inhibited by anti-rab5  antibodies, as 
expected (Gorvel et al., 1991), none of the other antibod- 
ies, including those against 13COP, had any effect on endo- 
some fusion (not  shown).  The fact that  anti-13COP  anti- 
bodies block ECV formation from early endosomes but 
not early endosome fusion, in contrast to anti-rab5  anti- 
ECV Formation Is Sensitive to the Vacuolar pH 
Our previous observations had shown that ECV formation 
is  abolished  after  inhibition  of the  vacuolar  ATPase  in 
vivo, whereas internalization into and recycling from early 
endosomes in vivo, or the fusion properties of early endo- 
somes in vitro are not affected (Clague et al.,  1994).  We 
therefore  measured  whether  in  vitro  budding  also  re- 
quired an active vacuolar ATPase. In our assay, ECV for- 
mation was inhibited to the same extent in the presence of 
10 p~M bafilomycinA1 or 100  nM concanamycinB (Fig. 7 
A), two specific inhibitors of the vacuolar ATPase (Bow- 
man et al., 1988; Woo et al., 1992; Villa et al., 1993). The 
extent  of  inhibition  was  similar  when  cells  were  pre- 
treated with either drug in vivo, or when the drug was di- 
rectly added to the assay in vitro. However, a combination 
of both treatments caused a more pronounced inhibition, 
presumably because of a  more efficient neutralization  of 
the endosomal pH (Yoshimori et al., 1991;  Clague et al., 
1994). In addition, replacement of KCI in the budding as- 
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Figure 6.  ECV formation depends on 13COP. (A) The assay measuring ECV formation in vitro was carried out as described  in the leg- 
end of Fig. 3, except that the mixture was preincubated for 60 rain on ice with the indicated  antibodies.  Control, no addition; P5D4, con- 
trol antibody as in Fig. 1 (D and E); anti-rab3a, antibody against the small GTPase rab3a; anti-rab5, antibody against the small GTPase 
tab5; anti-a adaptin, antibody against a adaptin; anti-ill ~2 adaptin, antibody against both 131 and 132 adaptins; M3A5, maD, A1, D1, an- 
tibodies against 13COP; CMIAIO, anti-coatomer antibody.  Vesicle formation is expressed as a percentage of the controls.  (B) Vesicle 
formation in vitro (as in Fig. 3) was measured after COP depletion.  To deplete endogenous COPs associated to endosomes, cells were 
pretreated with 10 ~M nigericin (see panel C and Fig. 7). This treatment was reversible,  since ECV formation in vitro was restored by 
control rat liver cytosol, which had been incubated for 90 min with an irrelevant antibody (P5D4) and then for 1 h with protein A-Seph- 
arose coupled to rabbit anti-mouse IgG (control,  see C). To deplete cytosolic coatomers, the cytosol was incubated as above, but with 
the CM1A10 anti-coatomer antibody (depleted, see C). ECV formation was inhibited  after depletion of both endosomal and cytosolic 
pools of COPs. ECV formation could be restored by the addition of 25% (Ixg/txg)  untreated cytosol to the assay (complete cytosol), but 
not by COP-depleted cytosol (depleted cytosol). Addition of extra cytosol had no effects on the controls. ECV formation could also be 
restored after addition of a coatomer-enriched fraction prepared by high speed centrifugation  of the cytosol (coatomer HSP). (C) SDS- 
gel and Western blotting analysis of 13 and eCOP distribution  in cytosol and early endosomes (EE) prepared as in B. 
say with  KOAc  decreased  the  efficiency of vesicle bud- 
ding, in agreement with the role of Cl- channels in mainte- 
nance of an acidic lumenal pH (Mellman et al., 1986), and 
with the finding that loss of function of the cystic fibrosis 
transmembrane regulator, which causes defective C1- con- 
ductance,  delays o~2-macroglobulin degradation  (Barasch 
et  al.,  1991).  Finally,  we  used  nigericin,  an  ionophore 
which exchanges protons and K + ions, to dissect the aci- 
dogenic and electrogenic properties of the vacuolar ATP- 
ase (Mellman et al., 1986). The inhibition observed in the 
presence of the drug (Fig. 7 A) demonstrates that vesicle 
formation in vitro was inhibited  by neutralization  of the 
lumenal pH. 
[3COP Association  to Endosomes Is Sensitive to the 
Vacuolar pH 
We then investigated whether 13COP association to endo- 
somal membranes was also sensitive to the lumenal pH. In 
these experiments, endosomes immunoisolated using the 
VSV-G protein as antigen were treated in the presence of 
cytosol under the same conditions as in the in vitro assay. 
A  quantitative Western blot analysis using different anti- 
13COP antibodies showed that the amounts of 13COP asso- 
ciated to early endosomal membranes were reduced to 55 
_-+ 5% of the control value by bafilomycinA1, to 35 _+ 5% 
by concanamycinB, and to 15 _  3% by nigericin (Fig. 7 B). 
We also used immunogold labeling and electron micros- 
copy to quantify the  amounts of 13COP present on early 
endosomes  after neutralization  of the  lumenal  pH with 
concanamycinB  or  bafilomycinA1  (not  shown).  These 
studies also showed that only 30 _+ 8% of the amounts of 
13COP present on control membranes remained associated 
to early endosomes after either drug treatment. The drugs 
did not cause endosome fragmentation, since 100 __+ 5% of 
the  transferrin  receptor present  in  the  control remained 
associated to immunoisolated endosomes after each treat- 
ment (Fig. 7 B). Neither did the drugs release rab5, which 
normally cycles between cytosol and  membranes (Zerial 
and Stenmark, 1993), or annexinlI, a peripheral protein of 
the early endosomal membrane (Emans et al.,  1993); for 
both  proteins,  95  _-+  5%  of the  amounts  present  in  the 
control  remained  associated  to  endosomes  after  each 
treatment.  This lumenal  pH dependence  was  specific to 
endosomes,  since  COP  association,  including  ",/COP,  to 
ERGIC53-containing  membranes (HM in  Fig.  1 A)  was 
not affected by the drugs (not shown). Finally, these drugs 
also caused COPs to be released from endosomal mem- 
branes in vivo, as illustrated by the effects of nigericin on 13 
and ~COP (Fig. 6 C). Therefore, we conclude that the for- 
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(A) The assay measuring ECV formation in vitro was carried out 
as described  in the legend of Fig. 3. A TP, in the presence of an 
ATP regenerating system (+) or an ATP-depleting system (-); 
Chloride, when indicated  (-) KC1 was replaced with KOAc; Baf 
A1 in vivo, the cells were pre-treated with 1 p.M bafilomycin A1 
for 30 min at 37°C, before HRP internalization;  BafA1, Con. B, 
and Nigericin, the donor early endosomal fraction was treated in 
vitro with the indicated  concentrations  of bafilomycin  A1, con- 
canamycin B or nigericin for 15 rain at 4°C in the absence of ATP, 
and then for 15 min in the presence of ATP and cytosol, before 
raising the temperature to 37°C. (B) Immunoisolated early endo- 
somes, prepared as in Fig. 1 B, were treated in vitro with 10 txM 
bafilomycin A1, 100 nM concanamycin  B, or 50 p~M nigericin as 
in A. Then, endosomal membranes were collected by centrifuga- 
tion and analyzed  by SDS-PAGE followed by Western blotting 
with  the M3A5  or E1  antibodies  against  13COP, or antibodies 
against  rab5,  the transferrin receptor and annexinlI. Each lane 
contained =10 txg protein. 
mation of ECVs from early endosomes depends on 13COP 
or a  closely related 13COP homologue, and that this pro- 
cess is regulated by the acidification properties of early en- 
dosomes. 
Discussion 
We  have  previously  shown  that,  both  in  polarized  and 
nonpolarized cells, membrane transport from early to late 
endosomes  occurs  via vesicular  intermediates  which  we 
termed ECVs (Gruenberg et al., 1989; Bomsel et al., 1990; 
Aniento et al., 1993a). Similar vesicles also mediate trans- 
port from early to late endosomes both in the axons and in 
the dendrites of cultured neurons (Parton et al., 1992). In 
this  paper  we  show  that  some,  but  not  all,  COPs  are 
present on endosomal membranes and are involved in the 
formation of ECVs from early endosomes in vitro. We ob- 
serve that neutralization of the endosomal pH either with 
specific inhibitors of the vacuolar ATPase or with the ion- 
ophore nigericin causes both a decrease in the amounts of 
COPs associated to early endosomes and an inhibition of 
the formation of ECVs from early endosomes. These ex- 
periments suggest that a  COP subcomplex is part of the 
mechanism regulating membrane transport from early to 
late endosomes, and that membrane association of endo- 
somal COPs depends on the acidic properties of the endo- 
somal milieu. 
Formation of ECVs  from Early Endosomes 
We have used an in vitro assay to reconstitute the forma- 
tion of ECVs from early endosomes. We find that ~10% 
of a  fluid phase tracer internalized  for 5  min  at 37°C  in 
vivo is packaged within vesicles formed in vitro with a tla 
~5 min. Our previous studies indicated that a similar frac- 
tion  of the  early endosomal content  is  packaged within 
ECVs over a 5-10-rain time period in vivo (Gruenberg et 
al.,  1989).  These observations may indicate  that  a  single 
round of vesicle formation was reconstituted in the assay. 
This process depends on the presence of cytosol and ATP 
and  is  inhibited  at low temperature.  Vesicles formed in 
vitro do not  originate from the  simple fragmentation of 
early  endosomes,  since  they  do  not  contain  the  small 
GTPase rab5, which is restricted to the plasma membrane 
and early endosomes in vivo even after 10--50-fold overex- 
pression (Chavrier et al.,  1990,  1991; Gorvel et al., 1991). 
Nor are these vesicles recycling endosomal vesicles, since 
they lack the  transferrin receptor, a  marker of the  recy- 
cling  pathway  (Hopkins,  1983;  Stoorvogel  et  al.,  1987; 
Mayor et al., 1993; Ghosh and Maxfield, 1995).  Additional 
evidence  that  vesicles formed in  vitro  are  not  recycling 
vesicles comes from our observations that vesicle forma- 
tion is inhibited after neutralization of the lumenal pH, as 
is ECV formation in vivo. In contrast, recycling of the en- 
dosomal content back to the cell surface is not sensitive to 
the  lumenal  pH  (Clague  et  al.,  1994).  Finally,  evidence 
that functional ECVs are formed from early endosomes in 
vitro comes from our observations that these vesicles are 
fusogenic with late endosomes, like ECVs formed in vivo 
(Aniento et al., 1993a; Bomsel et al., 1990). 
Our data  argue against a  gradual change of the mem- 
brane composition during passage from early to late endo- 
somes (Stoorvogel et al., 1991). Indeed, ECVs, but not do- 
nor early endosomes, have acquired the capacity to dock 
onto and fuse with late endosomes, and these  ECVs ex- 
clude  both  rab5  and  the  transferrin  receptor.  Our  data, 
thus, suggest that a strict compartment boundary exists on 
early endosomal membranes at the site of ECV formation. 
Coats and Endosomes 
With the exception of plasma membrane clathrin-coated 
pits, little is known about the role of coat proteins in the 
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presence of small clathrin-coated pits on early endosomal 
membranes,  presumably  involved  in  receptor  recycling 
back to the cell surface (Killisch et al., 1992). Non clathrin 
coats have also been observed on early endosomes (Par- 
ton,  R.,  unpublished  observations),  but  the  function  of 
these coats is unknown. In addition, expression of ~COP, a 
component of the COP coat required at early stages of the 
biosYnthetic pathway  (Kreis  and  Pepperkok,  1994),  was 
recently shown to correct pleiotropic membrane transport 
defects, including in the endocytic pathway, in the CHO 
ldlF mutant cell line (Guo et al., 1994; Hobbie et al., 1994). 
Our studies show that I3COP, another component of the 
COP coat, is present on early endosomes and is required 
for the  formation of ECVs,  the  vesicular intermediates 
destined for late endosomes. Consistent with the findings 
of Guo et al. (1994), we find that ~COP is also present on 
endosomes. However, all COP subunits do not appear to 
be shared by the endocytic and the biosynthetic pathways, 
since ~,COP is not detected in any of our different endo- 
some preparations.  These observations are  also in good 
agreement with the finding that [3, ~, and [COP, but not 
~COP, are associated to endosomes prepared by free-flow 
electrophoresis (Whitney, J.A., M. Gomez, T.E. Kreis, and 
I.  Mellman,  manuscript  submitted  for publication).  Al- 
though the precise function of endosomal COPs is not es- 
tablished,  our data,  examined in  the light of the known 
roles of coat proteins (Kreis and Pepperkok, 1994; Robin- 
son,  1994),  suggest  that  endosomal  COPs  contribute  to 
coat formation during vesicle transport from early to late 
endosomes. 
Endosomal and Biosynthetic COPs 
We find that some, but not all, antibodies against [3COP 
can inhibit ECV formation in vitro, suggesting that some 
epitopes only are accessible to antibodies when the pro- 
tein is bound  to endosomal membranes.  These observa- 
tions  may also  suggest  that  endosomal and  biosynthetic 
forms of [3COP are, at least to some extent, immunologi- 
cally distinct.  Indeed, several [3COP isoforms have been 
found in high resolution two-dimensional gels (Celis et al., 
1994),  presumably  reflecting  the  existence  of  different 
post-translational  modifications.  More  importantly,  the 
presence of [3, [, and ¢COP, but not "yCOP, on endosomes 
suggests that coatomer subcomplexes can exist, and that 13, 
[, and ¢COP may be part of the same subcomplex on en- 
dosomal membranes. Presumably, this subcomplex is asso- 
ciated to other, as yet unknown, components on endoso- 
real membranes. 
The mechanisms regulating both COP association to en- 
dosomes and ECV formation differ, at least to some ex- 
tent, from those regulating the formation of COP-coated 
vesicles in the biosynthetic pathway. Both ECV formation 
and COP association to endosomes are sensitive to the lu- 
menal pH. In contrast, biosynthetic COP-coated vesicles 
form on the membranes of nonacidic compartments (Mell- 
man  et  al.,  1986),  and  COP  association  to  ERGIC53- 
enriched membranes is pH insensitive. We also find that 
ECV formation is inhibited by GTP~tS, as is the formation 
of plasma membrane-derived clathrin-coated vesicles (Carter 
et al.,  1993) and secretory granules  (Tooze et al.,  1990), 
but in contrast to the budding of COP- or COPII-coated 
vesicles (Ostermann et al., 1993; Barlowe et al., 1994). How- 
ever, COP binding to endosomes is increased by GTP-/S, 
as  is  the  case  for Golgi membranes  (Donaldson  et  al., 
1990; Donaldson et al., 1992; Helms and Rothman, 1992; 
Palmer et al., 1993).  On Golgi membranes, both COP re- 
cruitment and vesicle formation are stimulated by GTP'yS 
via the small GTP-binding protein ARF1  (see Kreis and 
Pepperkok,  1994).  Since we find  that  GTP~/S stimulates 
COP association to endosomes but inhibits ECV forma- 
tion, it appears that these two processes are uncoupled in 
the endocytic pathway, presumably because they are regu- 
lated  by more  than  one  GTP-binding protein.  Alterna- 
tively, COP association to endosomes may be regulated by 
an  ARF  with  properties  distinct  from  ARF1.  Indeed, 
membrane  association  of ARF6,  which  has  been impli- 
cated  between plasma  membrane  and  early endosomes, 
does not depend on the bound nucleotide state and is in- 
sensitive to brefeldinA, in contrast to ARF1 (Peters et al., 
1994). 
Altogether, our observations indicate that the associa- 
tion of endosomal and biosynthetic COPs to membranes 
shares similar GTP dependence but is regulated, at least in 
part,  by different mechanisms.  Since  COP  subunits  are 
only partially shared by endosomal and biosynthetic mem- 
branes,  one  may  speculate  that  mechanistic  similarities 
and differences reflect the presence of common and spe- 
cific coat components, respectively. 
Acidification,  Membrane Transport, and COPs 
Our data show that COPs are directly involved in the for- 
mation of ECVs. Neutralization of the endosomal pH re- 
duces  the  amounts  of  COPs  associated  to  endosomal 
membranes, and concomitantly inhibits the formation of 
ECVs in vitro, as we had observed in vivo (Clague et al., 
1994).  These  observations  suggest  that  the  acidification 
properties of BHK early endosomes may control the for- 
mation of vesicles destined for late endosomes by control- 
ling coat recruitment onto the membranes.  This mecha- 
nism is consistent with the fact that the lumenal pH drops 
from early to late endosomes (Mellman et al.,  1986) and 
with the observation that ECVs can be more acidic than 
early endosomes (Killisch et al.,  1992). It is not clear how 
information on the lumenal pH may then be transferred to 
the cytoplasmic face of the membrane. The simplest view 
is  that  pH differences may be  sensed  by the  conforma- 
tional change of a membrane protein. Indeed, the confor- 
mation of trans-membrane proteins can be sensitive to the 
endosomal  pH  (Watts,  1984).  We,  therefore,  speculate 
that the conformation of an endosomal trans-membrane 
protein, possibly a COP receptor, is pH sensitive, and thus 
serves as a sensor of the endosomal pH. 
In  conclusion,  formation  of  transport  vesicles  at  the 
early endosomal membrane  appears  to  be regulated  by 
COP recruitment on the membrane in a  process depen- 
dent on the acidic milieu of early endosomes. This mecha- 
nism, which is also regulated by GTP-binding proteins, but 
not by tab5 present on early endosomes, may provide an 
appropriate means to regulate the formation of these rela- 
tively large and multivesicular carriers (Gruenberg et al., 
1989; Bomsel et al.,  1990; Aniento et al.,  1993a). One of 
Aniento et al. BCOP and pH in Endosomal Transport  39 our future goals will be to make use of our approach to 
study in more detail the formation of these vesicular inter- 
mediates, and, in particular, the precise role of coat pro- 
teins in this process. 
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